4Filed Aug 5, 8:00 PM ET

CareDx (CDNA) Director George Bickerstaff Sells 20,000 Shares

$CDNA · CareDx, Inc.

Research Summary

AI-generated summary of this SEC filing

Updated

CareDx (CDNA) Director George Bickerstaff Sells 20,000 Shares

What Happened
George Bickerstaff, a director of CareDx, sold 20,000 shares of CareDx common stock in an open-market transaction on August 5, 2026. The reported weighted-average price was $46.28 per share, for a total proceeds of approximately $925,700. This was a sale (not a purchase or award), which is often routine insider selling and does not by itself indicate the insider’s view of the company.

Key Details

  • Transaction date: 2026-08-05 (reported on Form 4 filed 2026-08-06). Filing appears timely (filed the next day).
  • Quantity and price: 20,000 shares sold; weighted-average price $46.28; total proceeds ≈ $925,700.
  • Price range: Shares were sold in multiple trades at prices from $46.14 to $47.06 per share (footnote indicates the $46.28 is a weighted average).
  • Shares owned after transaction: Not specified in the provided summary — consult the full Form 4 for post-transaction holdings.
  • Footnote: The reporting person will provide on request the number of shares sold at each separate price within the stated range.

Context

  • Sales by directors can be routine (e.g., diversification, liquidity) and do not necessarily signal negative information about the company. For investors, purchases typically carry more positive informational weight than sales.
  • No options were exercised and no awards, gifts, or tax-withholding events are indicated in this transaction.